Scholars Central

Conference abstract

Personalized medicine approach for the selection of effective therapy of severe drug resistant tuberculosis

Authors: Leonard Amaral

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Fully treatable tuberculosis with isoniazid and rifampicin has progressed to multi-drug resistant tuberculosis (MDR TB) and to increasingly more severe status of drug resistance extensively drug resistant (XDR). Most recently, totally drug resistant (TDR) tuberculosis has arisen in India in large numbers. Although the threat to global health is real and worrisome, the development of laboratory programs that fully characterize the infecting Mycobacterium tuberculosis strain for virulence, antibiotic susceptibility to first, second and promising drugs, over-expressed efflux pumps, the effectiveness of the patient?s macrophage for enhanced ex vivo killing of the clinical isolate by adjuvant drugsand the determination of drug sensitive latency of the isolate are components of the recommender programme that will be discussed in detail.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Microbiology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Microbiology: Open Access
  • SubjectMicrobiology
  • SubjectInfectious Diseases
  • BylineArticles whose byline prints “Leonard Amaral”